Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

1.21
Delayed Data
As of Dec 09
 +0.02 / +1.68%
Today’s Change
1.12
Today|||52-Week Range
3.25
-54.85%
Year-to-Date
Institutional investors purchased a net $86.0 thousand shares of GENE during the quarter ended June 2016, and now own 4.54% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders--
Individual stakeholders--
Other institutional--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

9/30/2016RENAISSANCE TECHNOLOGIES LLC  Bought 83.2 Thousand shares of Genetic Technologies Ltd
9/30/2016CITADEL ADVISORS LLC  Bought 10.6 Thousand shares of Genetic Technologies Ltd
9/30/2016UBS FINANCIAL SERVICES, INC.  Bought 1.0 Thousand shares of Genetic Technologies Ltd

Top 10 Owners of Genetic Technologies Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Renaissance Technologies LLC4.26%486,680623,437+83,200+20.62%
KCG Americas LLC0.12%13,61517,441-1,022-6.98%
Citadel Advisors LLC0.09%10,64813,640+10,648--
KMS Financial Services, Inc.0.02%2,7503,52300.00%
UBS Securities LLC0.01%1,6282,085-8,562-84.02%
UBS Financial Services, Inc.0.01%1,0001,281+1,000--
Morgan Stanley Smith Barney LLC (...0.01%1,0001,28100.00%
Cutler Group LP0.00%500641+500--
Financial Architects, Inc.0.00%35044800.00%
Deutsche Asset Management Investm...0.00%400512-38-8.68%

Top 10 Mutual Funds Holding Genetic Technologies Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change